The main mechanism is “ductal retrogression” at the onset of IPMN, in which the mature duct cells downregulate ductal markers such as SRY box 9 (SOX9) and present a morphology more similar to progenitor cells [78]. Here, SOX9 is linked to pancreatic intraductal papillary-mucinous neoplasm.